Cardio Diagnostics Holdings, Inc. (CDIOW) Stock Price & Analysis
Cardio Diagnostics Holdings, Inc. (CDIOW) — price $0.0096 (0.00%), as of the Nov 19, 2026 trading session.
Educational signal · not a buy or sell recommendation · How to read this
Cardio Diagnostics Holdings, Inc. · CDIOW
Cardio Diagnostics Holdings, Inc. specializes in developing and commercializing epigenetics-based clinical tests for cardiovascular disease, leveraging AI and genetic insights. The company offers a suite of diagnostic and risk assessment tools targeting coronary heart disease for various healthcare providers and employers.
Price as of Nov 19, 2026
Key Statistics
Not scored: this is a debt/preferred or other non-common instrument, or its reported market value does not match its share basis.
Price & valuation
| Measure | Value |
|---|---|
| Latest provided price | $0.0096 |
| Change on the day | 0.00% |
| Shares traded on the day | 6 |
Price & events
Other perspectives
Council score for Cardio Diagnostics Holdings (CDIOW): perspectives
Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.
Legends Council
3 lenses, 0 current
AI simulations built from the named investors' published principles. Not affiliated with, endorsed by, or the opinion of these individuals. How these lenses are built
Read on: Sep 11, 2026 · older than the 27 hours refresh window; not a current reading
Munger's Mindset
Balance Sheet & Valuation · historical
Read on: Apr 29, 2026 · older than the 27 hours refresh window; not a current reading
How to read these bars and different assessments
Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.
Bars show each model's ordered assessment on its own scale, not a probability or a comparable investment return. The adjacent words give the assessment; more filled segments indicate a stronger model reading.
On Apr 29, 2026, the Munger lens read the price at that time as undervalued against its own estimate of value.
Readings on this page are from Nov 20, 2026, except a card that shows its own read date.
What is Cardio Diagnostics Holdings (CDIOW), and what does it report?
Short answer · as of
A current FMP business description is unavailable; the listing and provider classification below are the available identity facts. Cardio Diagnostics Holdings, Inc. (CDIOW) is the company analyzed here. It employs 15 people. In Q3 FY2026 it reported revenue of $3,590 and net income of -$2M.
What do the latest results show for Cardio Diagnostics Holdings (CDIOW)?
Short answer · as of
The most recent reported quarter, Q3 FY2026, carried revenue of $3,590. Against analyst estimates the company has EPS beat 7 of the last 8 reports.
Quarterly income statement — 4 quarters
| Period | Revenue | Net income | EPS |
|---|---|---|---|
| Q3 FY2026 | $3,590 | -$2M | -$0.59 (diluted) |
| Q2 FY2026 | $5,360 | -$2M | -$0.51 (diluted) |
| Q1 FY2026 | $2,680 | -$2M | -$0.63 (diluted) |
| Q4 FY2025 | $3,555 | -$1M | -$0.80 (diluted) |
What are the financial strengths and risks for Cardio Diagnostics Holdings (CDIOW)?
Short answer · as of
The distress and quality screens read Altman Z -3.94 · Piotroski F 5. Trailing ratios: ROE -89.4% · current ratio 17.44 · earnings yield -120.4%.
Data-derived red flags
- Financial-distress signal — its Altman Z-Score of -3.94 sits in the distress zone (elevated bankruptcy risk).
- Negative return on equity (-89.4%) — the business is not currently generating profit on shareholder capital.
The records behind this page
Who holds the shares?
Institutional ownership reported through 13F filings.
Tracked investors
Which of the 16 named investors we follow held CDIOW in their latest 13F filing, and what they did against the filing before it.
None of the 16 tracked investors reported CDIOW in their latest 13F filing.
How to read these figures
These filings arrive after the quarter ends. Names appear as the provider lists them, not as a verified ranking, and without filing dates. Related managers can appear separately, so their shares are not added together. Tracked investors: each fund's own latest 13F, so funds that have not filed the newest quarter yet show their previous one; weight is the share of the fund's reported 13F value.
Machine-generated analysis by Stock Expert AI — model gemini-2.5-flash, generated Jun 14, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief.
Sources: the source register lists the 11 figures on this page — 8 from Financial Modeling Prep (FMP) and 3 with no recorded source. Its rows (value as shown, as-of date, tier and source link) are in the Markdown version of this page.
Publication details and research sources
- Published
- Research standards
- Methodology · Editorial policy · Corrections
- Report a number
- sedat@stockexpertai.com